New research spans mental health breakthroughs, infectious disease treatments, cancer therapy advances, dietary risks, and diabetes management innovations.

Light therapy demonstrates effectiveness in reducing depression symptoms and improving sleep quality in patients with neuropsychiatric disorders, according to a new meta-analysis from Medscape.

Daptomycin shows comparable effectiveness to vancomycin for treating methicillin-resistant staphylococcal endocarditis while offering a superior safety profile, potentially changing treatment protocols.

Asandeutertinib outperforms osimertinib in treating EGFR-mutated non-small cell lung cancer with brain metastases, improving intracranial response rates in an interim phase 2 trial analysis.

Processed meat consumption is linked to increased risk of gastric cancer and oesophageal adenocarcinoma, according to a multicentre cohort study highlighting dietary cancer prevention strategies.

England experiences significant ethnic health disparities, with younger ethnic minorities showing higher E. coli bloodstream infection rates and Asian individuals experiencing notably elevated antibiotic resistance.

Delaying methotrexate by one month for pneumococcal vaccination does not compromise disease control or increase joint damage in early rheumatoid arthritis patients over a one-year period.

Ivonescimab, an investigational bispecific antibody combined with chemotherapy, demonstrates survival benefits in advanced squamous non-small cell lung cancer compared to standard treatment in phase 3 trials.

Continuous glucose monitoring technology is expanding beyond type 1 diabetes, with growing evidence supporting its use in type 2 diabetes to improve glycemic control and patient engagement.